Morningstar

abrdn U.S. Small Cap Equity Fund Class R GNSRX

Morningstar Medalist Rating
Unlock
Medalist Rating as of See abrdn Investment Hub
  • NAV / 1-Day Return $37.86  /  −0.63 %
  • Fund Size $373.4M
  • Adjusted Expense Ratio 1.600%
  • Net Expense Ratio 1.610%
  • Fee Level: Distribution High
  • Share Class Type Retirement, Medium
  • Morningstar Category Small Blend
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $0
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 48%
NAV and 1-Day Return as of

Morningstar’s Analysis GNSRX

Will GNSRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable GNSRX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the GNSRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of GNSRX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

abrdn US Small Cap Equity R holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNSRX

More GNSRX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 26.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Ligand Pharmaceuticals Inc

2.89 10M
Healthcare

Q2 Holdings Inc

2.80 10M
Technology

Kiniksa Pharmaceuticals International PLC Class A

2.80 10M
Healthcare

Magnolia Oil & Gas Corp Class A

2.78 10M
Energy

Wintrust Financial Corp

2.68 10M
Financial Services

ANI Pharmaceuticals Inc

2.67 10M
Healthcare

WSFS Financial Corp

2.51 9M
Financial Services

Seacoast Banking Corp of Florida

2.48 9M
Financial Services

Supernus Pharmaceuticals Inc

2.48 9M
Healthcare

Ameris Bancorp

2.39 9M
Financial Services

Sponsor Center